Evidence map›Paper›PMID 22461617›Full record

ArticleEndocrinology2012

GATA4 is a critical regulator of gonadectomy-induced adrenocortical tumorigenesis in mice.

Justyna Krachulec, Melanie Vetter, Anja Schrade, Ann-Kathrin Löbs, Malgorzata Bielinska, Rebecca Cochran, Antti Kyrönlahti, Marjut Pihlajoki, Helka Parviainen, Patrick Y Jay and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Effect of Inactivation ofJournal of the Endocrine Society · 2022
    Article
  3. Genetic variations in the transcription factorsDrug design, development and therapy · 2019
    Article
  4. Steroidogenic differentiation and PKA signaling are programmed by histone methyltransferase EZH2 in the adrenal cortex.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  5. Article
  6. Article
  7. GATA factors in endocrine neoplasia.Molecular and cellular endocrinology · 2016
    Review
  8. Mouse models of adrenocortical tumors.Molecular and cellular endocrinology · 2016
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Justyna KrachulecDepartment of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri 63110, USA.
Melanie Vetter
Anja Schrade
Ann-Kathrin Löbs
Malgorzata Bielinska
Rebecca Cochran
Antti Kyrönlahti
Marjut Pihlajoki
Helka Parviainen
Patrick Y Jay
Markku Heikinheimo
David B Wilson
Mannheim University of Applied Sciences · DEHelsinki University Hospital · FIUniversity of Helsinki · FISt. Louis Children's Hospital · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Regulation of Steroidogenic Cell Differentiation in the MouseR01DK075618 · NIDDK · WASHINGTON UNIVERSITY · PI WILSON, DAVID B · 2007 to 2011
$1.4M
NIDDK NIH HHS DK075618NIDDK NIH HHS DK52574NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R01 DK075618
6 · The paper itself

Abstract

In response to gonadectomy certain inbred mouse strains develop sex steroidogenic adrenocortical neoplasms. One of the hallmarks of neoplastic transformation is expression of GATA4, a transcription factor normally present in gonadal but not adrenal steroidogenic cells of the adult mouse. To show that GATA4 directly modulates adrenocortical tumorigenesis and is not merely a marker of gonadal-like differentiation in the neoplasms, we studied mice with germline or conditional loss-of-function mutations in the Gata4 gene. Germline Gata4 haploinsufficiency was associated with attenuated tumor growth and reduced expression of sex steroidogenic genes in the adrenal glands of ovariectomized B6D2F1 and B6AF1 mice. At 12 months after ovariectomy, wild-type B6D2F1 mice had biochemical and histological evidence of adrenocortical estrogen production, whereas Gata4(+/-) B6D2F1 mice did not. Germline Gata4 haploinsufficiency exacerbated the secondary phenotype of postovariectomy obesity in B6D2F1 mice, presumably by limiting ectopic estrogen production in the adrenal glands. Amhr2-cre-mediated deletion of floxed Gata4 (Gata4(F)) in nascent adrenocortical neoplasms of ovariectomized B6.129 mice reduced tumor growth and the expression of gonadal-like markers in a Gata4(F) dose-dependent manner. We conclude that GATA4 is a key modifier of gonadectomy-induced adrenocortical neoplasia, postovariectomy obesity, and sex steroidogenic cell differentiation.

Indexed as

OvariectomyAdrenal CortexAdrenal Cortex NeoplasmsAnimalsCell Transformation, NeoplasticEstrogensFemaleGATA4 Transcription FactorGene Expression Regulation, NeoplasticGerm-Line MutationHaploinsufficiencyImmunohistochemistryMaleMiceMice, 129 StrainMice, Inbred C57BLEstrogensGATA4 Transcription Factor

Identifiers

PMID22461617
PMCPMC3359595
OpenAlexW2164198570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.